NDC 42385-921 – Atazanavir
Atazanavir Sulfate 200 mg/1 · Capsule · Oral
Product NDC42385-921
Product details
- Brand name
- Atazanavir
- Generic name
- Atazanavir
- Labeler
- Laurus Labs Limited
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA212579
- Marketed since
- April 30, 2021
- Listing expires
- December 31, 2026
- Pharmacologic class
- Protease Inhibitor
Active ingredients
- Atazanavir Sulfate 200 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 42385-921-48 | 10 BLISTER PACK in 1 CARTON (42385-921-48) / 6 CAPSULE in 1 BLISTER PACK (42385-921-06) | Apr 30, 2021 |
| 42385-921-60 | 60 CAPSULE in 1 BOTTLE (42385-921-60) | Apr 30, 2021 |
Other Atazanavir products
- 31722-653 Atazanavir Sulfate 150 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-654 Atazanavir Sulfate 200 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 31722-655 Atazanavir Sulfate 300 mg/1 · Capsule · Camber Pharmaceuticals, Inc.
- 42385-920 Atazanavir Sulfate 150 mg/1 · Capsule · Laurus Labs Limited
- 42385-922 Atazanavir Sulfate 300 mg/1 · Capsule · Laurus Labs Limited